In healthcare, antidotes to the fear of AI

From Novartis to Sanofi, the results achieved by certain pharmaceutical companies suggest that artificial intelligence can help us find treatments more quickly and make healthcare more humane

21 NOV 26
Translated by AI
Photo by Hush Naidoo Jade Photography on Unsplash

Photo by Hush Naidoo Jade Photography on Unsplash

It is advisable to monitor the daily news: there are antidotes to be found for the fear of AI. Today, Reuters reports that Novartis, thanks in part to artificial intelligence, has reduced the average time taken to identify a drug candidate from three years to 18–24 months. Sanofi reports having saved at least a year in the development of an experimental treatment for asthma. Meanwhile, at Newham Hospital in England, AI is helping to manage complaints: in six months, the response rate has risen from 60 to 92 per cent and the time taken to prepare draft replies has been more than halved. Every text is checked by staff, who can now devote more time to patients.
These are limited findings, some reported by companies, others by a public hospital. They suggest that this technology could help us seek treatment more quickly and make healthcare more humane. All it takes is a prophecy to worry about the future. To find some reason to be hopeful, sometimes all you need to do is read the news.